Non-invasive bilateral vagus nerve stimulation (BnVNS) for the preventive treatment of episodic migraine.

This clinical trial was designed to evaluate the impact of an interventional treatment on individuals suffering from migraines. The primary goal was to assess changes in the frequency and intensity of migraines, as well as secondary outcomes such as mood, stress, and overall quality of life.